Stigmatization of carrier status: social implications of heterozygote genetic screening programs
- PMID: 152585
- PMCID: PMC1654013
- DOI: 10.2105/ajph.68.11.1116
Stigmatization of carrier status: social implications of heterozygote genetic screening programs
Abstract
Possible latent psychological and social consequences ensuing from genetic screening programs need to be investigated during the planning phase of national genetic screening programs. The relatively few studies which have been performed to determine psychological, social, and economic consequences resulting from a genetic screening program are reviewed. Stigmatization of carrier-status, having major psychosocial implications in heterozygote genetic screening programs, is discussed and related to Erving Goffman's work in the area of stigmatization. Questions are raised regarding the relationship between such variables as religiosity and sex of the individual and acceptance of the status of newly identified carrier of a mutant gene. Severity of the deleterious gene and visibility of the carrier status are two important factors to consider in an estimation of potential stigma. Specific implications are discussed for four genetic diseases: Tay-Sachs, Sickle-Cell Anemia, Huntington's disease and Hemophilia.
Similar articles
-
Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.Am J Hum Genet. 1996 Oct;59(4):793-8. Am J Hum Genet. 1996. PMID: 8808593 Free PMC article.
-
Genetic screening: marvel or menace?Science. 1984 Jul 13;225(4658):138-44. doi: 10.1126/science.6729472. Science. 1984. PMID: 6729472
-
Prenatal genetic carrier testing using triple disease screening.JAMA. 1997 Oct 15;278(15):1268-72. JAMA. 1997. PMID: 9333269
-
Assessing ethnicity in preconception counseling: genetics--what nurse practitioners need to know.J Am Acad Nurse Pract. 2004 Nov;16(11):472-80. doi: 10.1111/j.1745-7599.2004.tb00426.x. J Am Acad Nurse Pract. 2004. PMID: 15617360 Review.
-
Genetic Carrier Screening in the Twenty-first Century.Clin Lab Med. 2016 Jun;36(2):277-88. doi: 10.1016/j.cll.2016.01.003. Epub 2016 Mar 5. Clin Lab Med. 2016. PMID: 27235912 Review.
Cited by
-
Psychosocial Impact of Huntington's Disease and Incentives to Improve Care for Affected Families in the Underserved Region of the Slovak Republic.J Pers Med. 2022 Nov 22;12(12):1941. doi: 10.3390/jpm12121941. J Pers Med. 2022. PMID: 36556162 Free PMC article.
-
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.Cochrane Database Syst Rev. 2018 Mar 14;3(3):CD010849. doi: 10.1002/14651858.CD010849.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 Oct 11;10:CD010849. doi: 10.1002/14651858.CD010849.pub4. PMID: 29537064 Free PMC article. Updated.
-
Anticipated stigma and blameless guilt: Mothers' evaluation of life with the sex-linked disorder, hypohidrotic ectodermal dysplasia (XHED).Soc Sci Med. 2016 Jun;158:141-8. doi: 10.1016/j.socscimed.2016.04.027. Epub 2016 Apr 25. Soc Sci Med. 2016. PMID: 27140840 Free PMC article.
-
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods.Am J Hum Genet. 1984 May;36(3):677-89. Am J Hum Genet. 1984. PMID: 6731441 Free PMC article.
-
The genetic testing of children. Working Party of the Clinical Genetics Society (UK).J Med Genet. 1994 Oct;31(10):785-97. doi: 10.1136/jmg.31.10.785. J Med Genet. 1994. PMID: 7837256 Free PMC article. No abstract available.
References
MeSH terms
LinkOut - more resources
Full Text Sources